Valeant Pharmaceuticals International, Inc. Provides Earnings Guidance for Fiscal 2013
operations between $1.5 billion - $1.75 billion.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
7.15 USD | +0.56% |
|
+5.30% | -10.85% |
1st Jan change | Capi. | |
---|---|---|
-10.85% | 2.62B | |
+54.07% | 809B | |
+38.95% | 621B | |
-7.05% | 351B | |
+15.44% | 319B | |
+5.72% | 289B | |
+14.21% | 238B | |
-0.45% | 221B | |
+14.58% | 218B | |
+7.42% | 166B |